u/Idntevncare · 88d ago8 prior · awaiting results
HEALTHCARE is a great value right now
Recently-IPO'd biotech with 5B market cap and 27 PE offers significant upside potential, trading at a discount relative to peers like DXCM; author sees path to 10-15B valuation within a couple years driven by revenue growth.
At post $18.42live price unavailable
1d+6.4%
3d+6.4%
1w+8.7%
1m+26.4%
3m—
6m—
1y—